A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

March 15, 2024

Study Completion Date

March 15, 2024

Conditions
NarcolepsyCataplexyExcessive Daytime Sleepiness
Interventions
DRUG

AXS-12 (reboxetine)

AXS-12 tablets, taken twice daily

DRUG

Placebo

Placebo tablets, taken twice daily

Trial Locations (50)

11040

Clinical Research Site, New Hyde Park

11230

Clinical Research Site, Brooklyn

19610

Clinical Research Site, Wyomissing

20815

Clinical Research Site, Chevy Chase

23188

Clinical Research Site, Williamsburg

28037

Clinical Research Site, Denver

28054

Clinical Research Site, Gastonia

28078

Clinical Research Site, Huntersville

29201

Clinical Research Site, Columbia

29425

Clinical Research Site, Charleston

30281

Clinical Research Site, Stockbridge

30315

Clinical Research Site, Atlanta

30328

Clinical Research Site, Atlanta

30501

Clinical Research Site, Gainesville

31210

Clinical Research Site, Macon

32789

Clinical Research Site, Winter Park

33016

Clinical Research Site, Miami Lakes

33122

Clinical Research Site, Doral

33176

Clinical Research Site, Miami

33511

Clinical Research Site, Brandon

33634

Clinical Research Site, Tampa

33707

Clinical Research Site, St. Petersburg

33765

Clinical Research Site, Clearwater

34741

Clinical Research Site, Kissimmee

35007

Clinical Research Site, Alabaster

45245

Clinical Research Site, Cincinnati

46804

Clinical Research Site, Fort Wayne

48377

Clinical Research Site, Novi

49008

Clinical Research Site, Kalamazoo

61637

Clinical Research Site, Peoria

63143

Clinical Research Site, Maplewood

77478

Clinical Research Site, Sugar Land

78229

Clinical Research Site, San Antonio

78731

Clinical Research Site, Austin

80301

Clinical Research Site, Boulder

80918

Clinical Research Site, Colorado Springs

85054

Clinical Research Site, Phoenix

85381

Clinical Research Site, Peoria

89106

Clinical Research Site, Las Vegas

90404

Clinical Research Site, Santa Monica

92103

Clinical Research Site, San Diego

92705

Clinical Research Site, Santa Ana

94063

Clinical Research Site, Redwood City

96817

Clinical Research Site, Honolulu

02459

Clinical Research Site, Newton

02747

Clinical Research Site, North Dartmouth

07764

Clinical Research Site, West Long Branch

L3R 1A3

Clinical Research Site, Markham

M4P 1P2

Clinical Research Site, Toronto

M5S 3A3

Clinical Research Site, Toronto

Sponsors
All Listed Sponsors
lead

Axsome Therapeutics, Inc.

INDUSTRY